Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine
- PMID: 35998506
- PMCID: PMC9385778
- DOI: 10.1016/j.intimp.2022.109161
Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine
Abstract
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is a highly pathogenic and transmissible virus. Infection caused by SARS-CoV-2 known as Coronavirus disease 2019 (COVID-19) can be severe, especially among high risk populations affected of underlying medical conditions. COVID-19 is characterized by the severe acute respiratory syndrome, a hyper inflammatory syndrome, vascular injury, microangiopathy and thrombosis. Antiviral drugs and immune modulating methods has been evaluated. So far, a particular therapeutic option has not been approved for COVID-19 and a variety of treatments have been studied for COVID-19 including, current treatment such as oxygen therapy, corticosteroids, antiviral agents until targeted therapy and vaccines which are diverse in each patient and have various outcomes. According to the findings of different in vitro and in vivo studies, some novel approach such as gene editing, cell based therapy, and immunotherapy may have significant potential in the treatment of COVID-19. Based on these findings, this paper aims to review the different strategies of treatment against COVID-19 and provide a summary from traditional and newer methods in curing COVID-19.
Keywords: Cell based therapy; Coronavirus; Immunotherapy; Vaccine.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy.Biomed Pharmacother. 2021 Jun;138:111518. doi: 10.1016/j.biopha.2021.111518. Epub 2021 Mar 16. Biomed Pharmacother. 2021. PMID: 33774315 Free PMC article. Review.
-
Pathogenesis-directed therapy of 2019 novel coronavirus disease.J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33073355 Review.
-
Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.Curr Mol Med. 2021;21(7):562-572. doi: 10.2174/1566524020666201203170230. Curr Mol Med. 2021. PMID: 33272178 Review.
-
Immune-Based Therapy for COVID-19.Adv Exp Med Biol. 2021;1318:449-468. doi: 10.1007/978-3-030-63761-3_26. Adv Exp Med Biol. 2021. PMID: 33973194
-
Recent Antiviral Treatment and Vaccination Strategies Against SARS-CoV-2.Klin Monbl Augenheilkd. 2021 May;238(5):569-578. doi: 10.1055/a-1423-8961. Epub 2021 May 21. Klin Monbl Augenheilkd. 2021. PMID: 34020485 English, German.
Cited by
-
COVID-19 Pandemic: Therapeutic Strategies and Vaccines.Int J Mol Sci. 2023 Dec 31;25(1):556. doi: 10.3390/ijms25010556. Int J Mol Sci. 2023. PMID: 38203727 Free PMC article.
-
Novel N-(3-ethynyl Phenyl)-6,7-bis(2-methoxyethoxy)Quinazoline-4-amine Derivatives: Synthesis, Characterization, Anti-cancer Activity, In-silico and DFT Studies.Anticancer Agents Med Chem. 2024;24(7):514-532. doi: 10.2174/0118715206276286231220055233. Anticancer Agents Med Chem. 2024. PMID: 38288814
-
Immunity and Coagulation in COVID-19.Int J Mol Sci. 2024 Oct 19;25(20):11267. doi: 10.3390/ijms252011267. Int J Mol Sci. 2024. PMID: 39457048 Free PMC article. Review.
-
Multi-epitopes vaccine design for surface glycoprotein against SARS-CoV-2 using immunoinformatic approach.Heliyon. 2024 Jan 10;10(2):e24186. doi: 10.1016/j.heliyon.2024.e24186. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38298616 Free PMC article.
-
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19.Heliyon. 2024 Feb 19;10(5):e26423. doi: 10.1016/j.heliyon.2024.e26423. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38434363 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous